Quick Search:

uzh logo
Browse by:
bullet
bullet
bullet
bullet

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-27330

Distler, J H W; Akhmetshina, A; Schett, G; Distler, O (2009). Monocyte chemoattractant proteins in the pathogenesis of systemic sclerosis. Rheumatology, 48(2):98-103.

[img]
Preview
Accepted Version
PDF
151kB

Abstract

Activation of the immune system and increased synthesis of extracellular matrix proteins by fibroblasts are hallmarks in the pathogenesis of SSc. The molecular mechanisms underlying the infiltration of inflammatory cells into the skin and the subsequent activation of fibroblasts are still largely unknown. Chemokines are a family of small molecules that are classified according to the position of the NH(2)-terminal cysteine motif. Recent data indicate that chemokines and in particular two members of the subfamily of monocyte chemoattractant proteins, MCP-1 (CCL-2) and MCP-3 (CCL-7), might be involved in the pathogenesis of SSc. MCP-1 and -3 are overexpressed by SSc fibroblasts and in skin lesions from SSc patients compared to healthy controls. MCP-1 and -3 are chemotactic for inflammatory cells and stimulate their migration into the skin. In addition to their pro-inflammatory effects, MCP-1 and -3 contribute to tissue fibrosis by activating the synthesis of extracellular matrix proteins in SSc fibroblasts. Therapeutic strategies targeting MCP-1 have revealed promising results in several animal models of SSc. Antagonists against the receptor CCR2 are currently tested in clinical trials of a variety of diseases and also represent interesting candidates for target-directed therapy in SSc.

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > Center for Integrative Human Physiology
04 Faculty of Medicine > University Hospital Zurich > Rheumatology Clinic and Institute of Physical Medicine
DDC:570 Life sciences; biology
610 Medicine & health
Date:February 2009
Deposited On:13 Jan 2010 10:36
Last Modified:19 Jan 2014 22:46
Publisher:Oxford University Press
ISSN:1462-0324
Additional Information:This is a pre-copy-editing, author-produced PDF of an article accepted for publication in Rheumatology following peer review. The definitive publisher-authenticated version Rheumatology 2009 48(2):98-103; doi:10.1093/rheumatology/ken401 is available online at: http://rheumatology.oxfordjournals.org/cgi/content/full/48/2/98
Free access at:Publisher DOI. An embargo period may apply.
Publisher DOI:10.1093/rheumatology/ken401
PubMed ID:18984611
Citations:Web of Science®. Times Cited: 30
Google Scholar™
Scopus®. Citation Count: 32

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page